Journal of Antimicrobial Chemotherapy

Article	Citations
ResFinder 4.0 for predictions of phenotypes from genotypes	1581
Detection of mobile genetic elements associated with antibiotic resistance in Salmonella enterica using a newly developed web tool: MobileElementFinder	288
COVID-19 and the potential long-term impact on antimicrobial resistance	227
Antibiotic use in patients with COVID-19: a ‘snapshot’ Infectious Diseases International Research Initiative (ID-IRI) survey	172
Epidemiology of mobile colistin resistance genes mcr-1 to mcr-9	161
Systematic review of mutations associated with resistance to the new and repurposedMycobacterium tuberculosisdrugs bedaquiline, clofazimine, linezolid, delamanid and pretomanid	125
The global prevalence and trend of human intestinal carriage of ESBL-producing Escherichia coli in the community	113
Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study	103
Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis	96
Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19	88
Sofosbuvir and daclatasvir compared with standard of care in the treatment of patients admitted to hospital with moderate or severe coronavirus infection (COVID-19): a randomized controlled trial	85
Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey	84
Optimal dose and safety of molnupiravir in patients with early SARS-CoV-2: a Phase I, open-label, dose-escalating, randomized controlled study	82
Implications of antibiotics use during the COVID-19 pandemic: present and future	82
EUCAST rapid antimicrobial susceptibility testing (RAST) in blood cultures: validation in 55 European laboratories	82
Favipiravir, an antiviral for COVID-19?	77
The impact of sofosbuvir/daclatasvir or ribavirin in patients with severe COVID-19	72
An observational cohort study of bacterial co-infection and implications for empirical antibiotic therapy in patients presenting with COVID-19 to hospitals in North West London	71
Development and validation of a UHPLC-MS/MS method for quantification of the prodrug remdesivir and its metabolite GS-441524: a tool for clinical pharmacokinetics of SARS-CoV-2/COVID-19 and Ebola viru	69
Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care: a single-centre, randomize	64
Large-scale assessment of antimicrobial resistance marker databases for genetic phenotype prediction: a systematic review	62
Hospital antibiotic prescribing patterns in adult patients according to the WHO Access, Watch and Reserve classification (AWaRe): results from a worldwide point prevalence survey in 69 countries	58
Clinical efficacy and safety of remdesivir in patients with COVID-19: a systematic review and network meta-analysis of randomized controlled trials	57
Carbapenemase-producing Enterobacterales causing secondary infections during the COVID-19 crisis at a New York City hospital	55
In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19	54

Ceftazidime/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: experience from a national registry study	51
Lopinavir pharmacokinetics in COVID-19 patients	50
Long-acting antiretrovirals: a new era for the management and prevention of HIV infection	48
Current and future perspectives in the treatment of multidrug-resistant Gram-negative infections	45
Early therapeutic monitoring of β-lactams and associated therapy outcomes in critically ill patients	44
Stopping lopinavir/ritonavir in COVID-19 patients: duration of the drug interacting effect	44
Real-world effectiveness of early remdesivir and sotrovimab in the highest-risk COVID-19 outpatients during the Omicron surge	43
The changing epidemiology of carbapenemase-producingKlebsiella pneumoniaein Italy: toward polyclonal evolution with emergence of high-risk lineages	43
In vitro activity of sulbactam/durlobactam against global isolates of carbapenem-resistant Acinetobacter baumannii	43
Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it	43
Oxazolidinones: mechanisms of resistance and mobile genetic elements involved	42
Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial	41
Effectiveness of remdesivir in patients with COVID-19 under mechanical ventilation in an Italian ICU	39
Determining the optimal dosing of a novel combination regimen of ceftazidime/avibactam with aztreonam against NDM-1-producing Enterobacteriaceae using a hollow-fibre infection model	37
Ancient and recent differences in the intrinsic susceptibility of Mycobacterium tuberculosis complex to pretomanid	37
Cefiderocol: a novel siderophore cephalosporin for multidrug-resistant Gram-negative bacterial infections	37
Haem is crucial for medium-dependent metronidazole resistance in clinical isolates of Clostridioides difficile	35
Exclusion of bacterial co-infection in COVID-19 using baseline inflammatory markers and their response to antibiotics	35
High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinicalNeisseria gonorrhoeaeisolates from 25 European countries, 2018	35
Molecular mechanisms driving thein vivodevelopment of OXA-10-mediated resistance to ceftolozane/tazobactam and ceftazidime/avibactam during treatment of XDRPseudomonas aeruginosainfectio	35
Relationship of vancomycin trough levels with acute kidney injury risk: an exposure–toxicity meta-analysis	35
Linezolid-resistant (Tn6246::fexB-poxtA) Enterococcus faecium strains colonizing humans and bovines on different continents: similarity without epidemiological link	34
Emergence of tigecycline- and eravacycline-resistant Tet(X4)-producing Enterobacteriaceae in the gut microbiota of healthy Singaporeans	34
Aztreonam/avibactam activity against clinical isolates of Enterobacterales collected in Europe, Asia and Latin America in 2019	34
In vitrosusceptibility ofMycobacterium abscessuscomplex and feasibility of standardizing treatment regimens	34
Impact of an antimicrobial stewardship programme on reducing broad-spectrum antibiotic use and its effect on carbapenem-resistantAcinetobacter baumannii(CRAb) in hospitals in Jordan	33
Increasing frequency of OXA-48-producing Enterobacterales worldwide and activity of ceftazidime/avibactam, meropenem/vaborbactam and comparators against these isolates	33
Evaluation of the in vitro activity of new polymyxin B analogue SPR206 against clinical MDR, colistin-resistant and tigecycline-resistant Gram-negative bacilli	32
Activity of imipenem/relebactam against Pseudomonas aeruginosa producing ESBLs and carbapenemases	32
Real-life experience with bictegravir/emtricitabine/tenofovir alafenamide in a large reference clinical centre	32
Clofazimine pharmacokinetics in patients with TB: dosing implications	32
Consumption of antibiotics in the community, European Union/European Economic Area, 1997–2017	31
IS26-mediated amplification of blaOXA-1 and blaCTX-M-15 with concurrent outer membrane porin disruption associated with de novo carbapenem resistance in a recurrent bactera	31
Dissemination of the blaCTX-M-15 gene among Enterobacteriaceae via outer membrane vesicles	31
Genomic epidemiology of Neisseria gonorrhoeae elucidating the gonococcal antimicrobial resistance and lineages/sublineages across Brazil, 2015–16	30
Impact of ceftazidime/avibactam versus best available therapy on mortality from infections caused by carbapenemase-producing Enterobacterales (CAVICOR study)	30
Prevalence of antimicrobial resistance genes and its association with restricted antimicrobial use in food-producing animals: a systematic review and meta-analysis	30
Intrapulmonary pharmacokinetic profile of cefiderocol in mechanically ventilated patients with pneumonia	30
Genetically related micafungin-resistant Candida parapsilosis blood isolates harbouring novel mutation R658G in hotspot 1 of Fks1p: a new challenge?	30
AMR-Intervene: a social–ecological framework to capture the diversity of actions to tackle antimicrobial resistance from a One Health perspective	30
An update on cefepime and its future role in combination with novel β-lactamase inhibitors for MDR Enterobacterales and Pseudomonas aeruginosa	29
Large diversity of linezolid-resistant isolates discovered in food-producing animals through linezolid selective monitoring in Belgium in 2019	29
Transferable Acinetobacter baumannii plasmid pDETAB2 encodes OXA-58 and NDM-1 and represents a new class of antibiotic resistance plasmids	29
Antibiotics and healthcare facility-associatedClostridioides difficileinfection: systematic review and meta-analysis 2020 update	28
Sustained transmission of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone in China	28
Pharmacokinetics of remdesivir in a COVID-19 patient with end-stage renal disease on intermittent haemodialysis	28
Activity of β-lactam/taniborbactam (VNRX-5133) combinations against carbapenem-resistant Gram-negative bacteria	28
Do high MICs predict the outcome in invasive fusariosis?	28
Lopinavir/ritonavir in COVID-19 patients: maybe yes, but at what dose?	28
Drug interactions: a review of the unseen danger of experimental COVID-19 therapies	28

Molecular mechanisms of acquired antifungal drug resistance in principal fungal pathogens and EUCAST guidance for their laboratory detection and clinical implications	27
Impact of remdesivir according to the pre-admission symptom duration in patients with COVID-19	27
Evolution of β-lactamase-mediated cefiderocol resistance	27
Prevalence and genomic analysis of ESBL-producingEscherichia coliin retail raw meats in Singapore	27
Effect of remdesivir on viral dynamics in COVID-19 hospitalized patients: a modelling analysis of the randomized, controlled, open-label DisCoVeRy trial	26
A novel in silico antimicrobial peptide DP7 combats MDR Pseudomonas aeruginosa and related biofilm infections	26
Studies on the role of IS1216E in the formation and dissemination of poxtA-carrying plasmids in an Enterococcus faecium clade A1 isolate	26
Molecular and biochemical insights into the in vivo evolution of AmpC-mediated resistance to ceftolozane/tazobactam during treatment of an MDR Pseudomonas aeruginosa infection	26
ESBL-producing strains isolated from imported cases of enteric fever in England and Wales reveal multiple chromosomal integrations of blaCTX-M-15 in XDR Salmonella Typhi	26
In vitroactivity of the novel antifungal olorofim against dermatophytes and opportunistic moulds includingPenicilliumandTalaromycesspecies	26
Antimicrobial-induced horizontal transfer of antimicrobial resistance genes in bacteria: a mini-review	26
High percentage of the ceftriaxone-resistantNeisseria gonorrhoeaeFC428 clone among isolates from a single hospital in Hangzhou, China	26
Sofosbuvir/daclatasvir regimens for the treatment of COVID-19: an individual patient data meta-analysis	25
In vitro activity of olorofim against clinical isolates of Scedosporium species and Lomentospora prolificans using EUCAST and CLSI methodologies	25
Antimicrobial susceptibility of Corynebacterium diphtheriae and Corynebacterium ulcerans in Germany 2011–17	25
Global consumption of antimicrobials: impact of the WHO Global Action Plan on Antimicrobial Resistance and 2019 coronavirus pandemic (COVID-19)	25
On the island of Zanzibar people in the community are frequently colonized with the same MDR Enterobacterales found in poultry and retailed chicken meat	25
Oral cephalosporin and β-lactamase inhibitor combinations for ESBL-producing Enterobacteriaceae urinary tract infections	25
Activity of imipenem/relebactam against a Spanish nationwide collection of carbapenemase-producing Enterobacterales	25
Pharmacokinetics and safety of high-dose rifampicin in children with TB: the Opti-Rif trial	25
Molecular epidemiology of carbapenemase-producingEscherichia colifrom duck farms in south-east coastal China	25
In vitro dynamics and mechanisms of resistance development to imipenem and imipenem/relebactam in Pseudomonas aeruginosa	24
Towards personalized guidelines: using machine-learning algorithms to guide antimicrobial selection	24
One Health compartmental analysis of ESBL-producing Escherichia coli on Reunion Island reveals partitioning between humans and livestock	24
Phenotypic and genotypic analysis of KPC-51 and KPC-52, two novel KPC-2 variants conferring resistance to ceftazidime/avibactam in the KPC-producing Klebsiella pneumoniae ST11 clone background	24
Susceptibility profiles and resistance genomics of Pseudomonas aeruginosa isolates from European ICUs participating in the ASPIRE-ICU trial	24
Extensive antimicrobial resistance mobilization via multicopy plasmid encapsidation mediated by temperate phages	24
Vancomycin-resistant Enterococcus faecium colonizing patients on hospital admission in Germany: prevalence and molecular epidemiology	24
Detection ofmcr-9-harbouring ESBL-producingSalmonellaNewport isolated from an outbreak in a large-animal teaching hospital in the USA	24
Molecular dynamics simulations informed by membrane lipidomics reveal the structure–interaction relationship of polymyxins with the lipid A-based outer membrane of Acinetobacter baumannii	24
Real-time TDM-based optimization of continuous-infusion meropenem for improving treatment outcome of febrile neutropenia in oncohaematological patients: results from a prospective, monocentric, interv	24
Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: Week 96 results of ART-PRO pilot study	24
Emergence of a multidrug resistance efflux pump with carbapenem resistance gene blaVIM-2 in a Pseudomonas putida megaplasmid of migratory bird origin	24
Delamanid or pretomanid? A Solomonic judgement!	24
Treatment of methicillin-resistant Staphylococcus aureus (MRSA): updated guidelines from the UK	23
Cefiderocol: EUCAST criteria for disc diffusion and broth microdilution for antimicrobial susceptibility testing	23
Ganciclovir therapeutic drug monitoring in transplant recipients	23
Pharmacokinetics of antiretroviral and tuberculosis drugs in children with HIV/TB co-infection: a systematic review	23
Clinical practice guidelines for therapeutic drug monitoring of teicoplanin: a consensus review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring	23
In vitroactivity of rifabutin against 293 contemporary carbapenem-resistantAcinetobacter baumanniiclinical isolates and characterization of rifabutin mode of action and resistance mechan	23
Characterization of AmpC-hyperproducing Escherichia coli from humans and dairy farms collected in parallel in the same geographical region	22
A review of remdesivir for COVID-19 in pregnancy and lactation	22
Effective antimicrobial combination in vivo treatment predicted with microcalorimetry screening	22
Novel tigecycline resistance gene cluster tnfxB3-tmexCD3-toprJ1b in Proteus spp. and Pseudomonas aeruginosa, co-existing with tet(X6) on an SXT/R391 integrative and	22
A Phase III multicentre, randomized, double-blind trial to evaluate the efficacy and safety of oral contezolid versus linezolid in adults with complicated skin and soft tissue infections	22
Murepavadin antimicrobial activity against and resistance development in cystic fibrosis Pseudomonas aeruginosa isolates	22
A novel plasmid-borne tet(X6) variant co-existing with blaNDM-1 and blaOXA-58 in a chicken Acinetobacter baumannii isolate	22
Syndromic diagnostic testing: a new way to approach patient care in the treatment of infectious diseases	22
Preliminary view of the global distribution and spread of the tet(X) family of tigecycline resistance genes	22
Susceptibility trends of ceftolozane/tazobactam and comparators when tested against European Gram-negative bacterial surveillance isolates collected during 2012–18	22
In vivopharmacodynamics of new-generation β-lactamase inhibitor taniborbactam (formerly VNRX-5133) in combination with cefepime against serine-β-lactamase-producing Gram-negative bacteria	22
IV and oral fosfomycin pharmacokinetics in neonates with suspected clinical sepsis	22
Characterization of Klebsiella pneumoniae complex isolates from pigs and humans in farms in Thailand: population genomic structure, antibiotic resistance and virulence genes	22
Class D β-lactamases	22
Antimicrobial stewardship challenges and innovative initiatives in the acute hospital setting during the COVID-19 pandemic	22
In vitroactivity of imipenem/relebactam, meropenem/vaborbactam, ceftazidime/avibactam, cefepime/zidebactam and other novel antibiotics against imipenem-non-susceptible Gram-negative bacilli fro	21
Characterization of novel ISAba1-bounded tet(X15)-bearing composite transposon Tn6866 in Acinetobacter variabilis	21
The effect of N-acetylcysteine in a combined antibiofilm treatment against antibiotic-resistant Staphylococcus aureus	21
Incidence of diabetes in HIV-infected patients treated with first-line integrase strand transfer inhibitors: a French multicentre retrospective study	21
Combination treatment of liposomal amphotericin B and isavuconazole is synergistic in treating experimental mucormycosis	21
IS26cannot move alone	21
Prevalence of RND efflux pump regulator variants associated with tigecycline resistance in carbapenem-resistant Acinetobacter baumannii from a worldwide survey	21
Inherent colistin resistance in genogroups of the Enterobacter cloacae complex: epidemiological, genetic and biochemical analysis from the BSAC Resistance Surveillance Programme	21
Characterization and outcome of invasive infections due toPaecilomyces variotii: analysis of patients from the FungiScope® registry and literature reports	21
Neisseria gonorrhoeaeSequence Typing for Antimicrobial Resistance (NG-STAR) clonal complexes are consistent with genomic phylogeny and provide simple nomenclature, rapid visualization and antim	21
Revealing antibiotic cross-resistance patterns in hospitalized patients through Bayesian network modelling	21
Phenotypic resistance to lenacapavir and monotherapy efficacy in a proof-of-concept clinical study	21
Combination versus monotherapy as definitive treatment for Pseudomonas aeruginosa bacteraemia: a multicentre retrospective observational cohort study	21
Rationale of a loading dose initiation for hydroxychloroquine treatment in COVID-19 infection in the DisCoVeRy trial	21
Activity of meropenem/vaborbactam and comparators against Gram-negative isolates from Eastern and Western European patients hospitalized with pneumonia including ventilator-associated pneumonia (2014–	21
Novel IncFII plasmid harbouring blaNDM-4 in a carbapenem-resistant Escherichia coli of pig origin, Italy	21
Changing molecular epidemiology and characteristics of MRSA isolated from bloodstream infections: nationwide surveillance in Japan in 2019	21
Application of the hollow fibre infection model (HFIM) in antimicrobial development: a systematic review and recommendations of reporting	21
Defining the scope of the European Antimicrobial Resistance Surveillance network in Veterinary medicine (EARS-Vet): a bottom-up and One Health approach	20
Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam- and ceftazidime/avibactam-resistant Pseudomonas aeruginosa	20
Pharmacokinetic modelling to estimate intracellular favipiravir ribofuranosyl-5′-triphosphate exposure to support posology for SARS-CoV-2	20
Epidemiology, clinical aspects, outcomes and prognostic factors associated with Trichosporon fungaemia: results of an international multicentre study carried out at 23 medical centres	20
Bloodstream infection by two subpopulations of Klebsiella pneumoniae ST1685 carrying KPC-33 or KPC-14 following ceftazidime/avibactam treatment: considerations regarding acquired heteroresistance and	20
Spread of hypervirulent multidrug-resistant ST147 Klebsiella pneumoniae in patients with severe COVID-19: an observational study from Italy, 2020–21	20
Identification of thresholds in relationships between specific antibiotic use and carbapenem-resistant Acinetobacter baumannii (CRAb) incidence rates in hospitalized patients in Jordan	20

Carbapenemase-producing Enterobacteriaceae in transplant patients	20
Comparative phylogenomics of ESBL-, AmpC- and carbapenemase-producing Klebsiella pneumoniae originating from companion animals and humans	20
Outpatient parenteral antimicrobial therapy (OPAT) in the UK: findings from the BSAC National Outcomes Registry (2015–19)	19
Multiplex real-time PCR assays for the prediction of cephalosporin, ciprofloxacin and azithromycin antimicrobial susceptibility of positive Neisseria gonorrhoeae nucleic acid amplification test	19
Short versus prolonged courses of antimicrobial therapy for patients with uncomplicated Pseudomonas aeruginosa bloodstream infection: a retrospective study	19
Rapid spread of critical priority carbapenemase-producing pathogens in companion animals: a One Health challenge for a post-pandemic world	19
Predictors of mortality and clinical characteristics among carbapenem-resistant or carbapenemase-producing Enterobacteriaceae bloodstream infections in Spanish children	19
Establishing essential metrics for antifungal stewardship in hospitals: the results of an international Delphi survey	19
AbGRI4, a novel antibiotic resistance island in multiply antibiotic-resistant Acinetobacter baumannii clinical isolates	19
De-escalation of antimicrobial therapy in ICU settings with high prevalence of multidrug-resistant bacteria: a multicentre prospective observational cohort study in patients with sepsis or septic shoc	19
Novel SCCmec type XV (7A) and two pseudo-SCCmec variants in foodborne MRSA in China	19
Dynamic evolution of imipenem/relebactam resistance in a KPC-producing Klebsiella pneumoniae from a single patient during ceftazidime/avibactam-based treatments	19
Occurrence of a plasmid co-carrying cfr(D) and poxtA2 linezolid resistance genes in Enterococcus faecalis and Enterococcus casseliflavus from porcine manure, Italy	19
Treating COVID-19: are we missing out the window of opportunity?	19
Anti-HBV activity of the HBV capsid assembly modulator JNJ-56136379 across full-length genotype A–H clinical isolates and core site-directed mutants in vitro	19
Important considerations regarding the widespread use of doxycycline chemoprophylaxis against sexually transmitted infections	19
An open randomized multicentre Phase 2 trial to assess the safety of DAV132 and its efficacy to protect gut microbiota diversity in hospitalized patients treated with fluoroquinolones	19
Molecular pathways to high-level azithromycin resistance in Neisseria gonorrhoeae	19
Optimization of flucloxacillin dosing regimens in critically ill patients using population pharmacokinetic modelling of total and unbound concentrations	19
Impact of antibiotic timing on mortality from Gram-negative bacteraemia in an English district general hospital: the importance of getting it right every time	18
Invasive infections withPurpureocillium lilacinum: clinical characteristics and outcome of 101 cases from FungiScope® and the literature	18
EUCAST rapid antimicrobial susceptibility testing (RAST): analytical performance and impact on patient management	18
COVID-19, antibiotics and One Health: a UK environmental risk assessment	18
Pyocin efficacy in a murine model of Pseudomonas aeruginosa sepsis	18
Spread of ESC-, carbapenem- and colistin-resistant Escherichia coli clones and plasmids within and between food workers in Lebanon	18
Role of new antibiotics for KPC-producingKlebsiella pneumoniae	18
Shutting the gate before the horse has bolted: is it time for a conversation about SARS-CoV-2 and antiviral drug resistance?	18
In vitro activity of cefepime/zidebactam and cefepime/taniborbactam against aztreonam/avibactam-resistant NDM-like-producing Escherichia coli clinical isolates	18
Emergence of a Neisseria gonorrhoeae clone with reduced cephalosporin susceptibility between 2014 and 2019 in Amsterdam, The Netherlands, revealed by genomic population analysis	18
Mechanisms of antibiotic resistance of Clostridioides difficile	18
Assessing the accuracy of two Bayesian forecasting programs in estimating vancomycin drug exposure	18
Characterization of carbapenemase-producingSerratia marcescensand whole-genome sequencing for plasmid typing in a hospital in Madrid, Spain (2016–18)	17
Point prevalence survey of antibiotic use in hospitals in Latin American countries	17
Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenation	17
Phenotypic and genomic analysis reveals Riemerella anatipestifer as the potential reservoir of tet(X) variants	17
Comparative genomics of ESBL-producingEscherichia coli(ESBL-Ec) reveals a similar distribution of the 10 most prevalent ESBL-Ec clones and ESBL genes among human community faecal and extra-inte	17
Pragmatic options for dose optimization of ceftazidime/avibactam with aztreonam in complex patients	17
Respiratory antibacterial prescribing in primary care and the COVID-19 pandemic in England, winter season 2020–21	17
Consumption of quinolones in the community, European Union/European Economic Area, 1997–2017	17
Activity of cefepime/zidebactam against MDR Escherichia coli isolates harbouring a novel mechanism of resistance based on four-amino-acid inserts in PBP3	17
Impact of duration of antibiotic therapy in central venous catheter-related bloodstream infection due to Gram-negative bacilli	17
Mobile oxazolidinone/phenicol resistance gene optrA in chicken Clostridium perfringens	17
Activity of cefepime/zidebactam (WCK 5222) against ‘problem’ antibiotic-resistant Gram-negative bacteria sent to a national reference laboratory	17
Outcome of community-onset ESBL-producing Escherichia coli and Klebsiella pneumoniae bacteraemia and urinary tract infection: a population-based cohort study in Denmark	17
Relevance of the Consensus Principles for Appropriate Antibiotic Prescribing in 2022	16
Clinical experience with SUBA-itraconazole at a tertiary paediatric hospital	16
Macrolide resistance and molecular typing of Mycoplasma pneumoniae infections during a 4 year period in Spain	16
Optimizing pharmacokinetics/pharmacodynamics of β-lactam/β-lactamase inhibitor combinations against high inocula of ESBL-producing bacteria	16
Treatment efficacy for pharyngeal Neisseria gonorrhoeae: a systematic review and meta-analysis of randomized controlled trials	16
Two high-risk clones of carbapenemase-producing Klebsiella pneumoniae that cause infections in pets and are present in the environment of a veterinary referral hospital	16
Inhibition of SARS-CoV-2 in Vero cell cultures by peptide-conjugated morpholino oligomers	16
Survival benefit of remdesivir in hospitalized COVID-19 patients with high SARS-CoV-2 viral loads and low-grade systemic inflammation	16
Efficacy of dalbavancin against MRSA biofilms in a rat model of orthopaedic implant-associated infection	16
A nationwide genomic study of clinical Klebsiella pneumoniae in Norway 2001–15: introduction and spread of ESBLs facilitated by clonal groups CG15 and CG307	16
Microevolution of acquired colistin resistance in Enterobacteriaceae from ICU patients receiving selective decontamination of the digestive tract	16
Targeted SARS-CoV-2 treatment is associated with decreased mortality in immunocompromised patients with COVID-19	16
Antifungal activity of nikkomycin Z against Candida auris	16
Carprofen elicits pleiotropic mechanisms of bactericidal action with the potential to reverse antimicrobial drug resistance in tuberculosis	16
Do specific antimicrobial stewardship interventions have an impact on carbapenem resistance in Gram-negative bacilli? A multicentre quasi-experimental ecological study: time-trend analysis and charact	16
An outbreak of multiply antibiotic-resistant ST49:ST128:KL11:OCL8Acinetobacter baumanniiisolates at a Sydney hospital	16
Resistance/fitness trade-off is a barrier to the evolution of MarR inactivation mutants in Escherichia coli	16
Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society	16
Dalbavancin for the management of osteomyelitis: a major step forward?	16
Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control	16
In vitro and in vivo synergistic effects of tigecycline combined with aminoglycosides on carbapenem-resistant Klebsiella pneumoniae	16
High prevalence and risk factors of multiple antibiotic resistance in patients who fail first-line Helicobacter pylori therapy in southern China: a municipality-wide, multicentre, prospective cohort s	16
Susceptibility of Elizabethkingia spp. to commonly tested and novel antibiotics and concordance between broth microdilution and automated testing methods	16
When to change treatment of acute invasive aspergillosis: an expert viewpoint	16
Detection in livestock of the human pandemic Escherichia coli ST131 fimH30(R) clone carrying blaCTX-M-27	16
Detecting carbapenemase-producing Enterobacterales (CPE): an evaluation of an enhanced CPE infection control and screening programme in acute care	16
Legionellaantibiotic susceptibility testing: is it time for international standardization and evidence-based guidance?	15
Management ofClostridioides difficileinfection in adults and challenges in clinical practice: review and comparison of current IDSA/SHEA, ESCMID and ASID guidelines	15
Re-engineering a mobile-CRISPR/Cas9 system for antimicrobial resistance gene curing and immunization inEscherichia coli	15
Azithromycin in patients with COVID-19: a systematic review and meta-analysis	15
Emergence of livestock-associated MRSA ST398 from bulk tank milk, China	15
Efficacy of ensitrelvir against SARS-CoV-2 in a delayed-treatment mouse model	15
A novel colistin adjuvant identified by virtual screening for ArnT inhibitors	15
Acquisition of a genomic resistance island (AbGRI5) from global clone 2 through homologous recombination in a clinical Acinetobacter baumannii isolate	15
The impact of digital interventions on antimicrobial stewardship in hospitals: a qualitative synthesis of systematic reviews	15
Linezolid toxicity in patients with drug-resistant tuberculosis: a prospective cohort study	15
Efficacy comparison of 3CL protease inhibitors ensitrelvir and nirmatrelvir against SARS-CoV-2in vitroandin vivo	15
AUCs and 123s: a critical appraisal of vancomycin therapeutic drug monitoring in paediatrics	15
Safety and efficacy of fumagillin for the treatment of intestinal microsporidiosis. A French prospective cohort study	15
Genomic analysis of 600 vancomycin-resistant Enterococcus faecium reveals a high prevalence of ST80 and spread of similar vanA regions via IS1216E and plasmid transfer in diverse	15
The impact of anti-mould prophylaxis on Aspergillus PCR blood testing for the diagnosis of invasive aspergillosis	15
Emergence and genomic characterization of the ceftriaxone-resistant Neisseria gonorrhoeae FC428 clone in Chengdu, China	15
Identification of 16S rRNA mutations in Mycoplasma genitalium potentially associated with tetracycline resistance in vivo but not selected in vitro in M. genitalium and	15
The bla and mec families of β-lactam resistance genes in the genera Macrococcus, Mammaliicoccus and Staphylococcus: an in-depth analysis with emphasis on Macrococ	15
Assessing the in vitro impact of ceftazidime on aztreonam/avibactam susceptibility testing for highly resistant MBL-producing Enterobacterales	15
Local characteristics associated with higher prevalence of ESBL-producing Escherichia coli in community-acquired urinary tract infections: an observational, cross-sectional study	15
An updated phylogeny of the metallo-β-lactamases	14
Using a public database of Neisseria gonorrhoeae genomes to detect mutations associated with zoliflodacin resistance	14
Surveillance of HIV-1 transmitted integrase strand transfer inhibitor resistance in the UK	14
Thiocillin and micrococcin exploit the ferrioxamine receptor of Pseudomonas aeruginosa for uptake	14
Optical maps of plasmids as a proxy for clonal spread of MDR bacteria: a case study of an outbreak in a rural Ethiopian hospital	14